Arrowhead Pharmaceuticals (ARWR) Receivables (2010 - 2026)
Arrowhead Pharmaceuticals (ARWR) posted Receivables of $15.7 million for Q1 2026, down 93.13% on a QoQ basis from $228.2 million in Q4 2025, and up 563.21% year-over-year from $2.4 million in Q1 2025.
Arrowhead Pharmaceuticals (ARWR) Receivables (2010 - 2026) Analysis & Trends
Arrowhead Pharmaceuticals' Receivables history runs 15 years deep, the most recent figure standing at $15.7 million for Q1 2026.
- Quarterly Receivables rose 563.21% year-over-year to $15.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15.7 million (up 563.21% YoY) and the FY2025 annual result came in at $6.8 million, changed N/A from the prior year.
- Receivables was $15.7 million for Q1 2026 at Arrowhead Pharmaceuticals, down from $228.2 million in the prior quarter.
- Across five years, Receivables topped out at $228.2 million in Q4 2025 and bottomed at $239000.0 in Q2 2022.
- A 5-year average of $33.5 million and a median of $6.5 million in 2022 frame the typical range for Receivables.
- Peak annual rise in Receivables reached 36278.67% in 2022, while the deepest fall reached 77.68% in 2022.
- Arrowhead Pharmaceuticals' Receivables stood at $54.6 million in 2022, then sank by 94.43% to $3.0 million in 2023, then dropped by 17.74% to $2.5 million in 2024, then jumped by 9027.24% to $228.2 million in 2025, then plunged by 93.13% to $15.7 million in 2026.
- Business Quant data shows ARWR's Receivables at $15.7 million in Q1 2026, $228.2 million in Q4 2025, and $6.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 4.97 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 938.02 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 1.13 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.00 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5.73 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.93 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Arrowhead Pharmaceuticals | 11.98 Bn | 10.18 Bn | - | 15.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.69 Mn |
| Dec 31, 2025 | 228.18 Mn |
| Sep 30, 2025 | 6.82 Mn |
| Jun 30, 2025 | 9.70 Mn |
| Mar 31, 2025 | 2.37 Mn |
| Dec 31, 2024 | 2.50 Mn |
| Jun 30, 2023 | 3.04 Mn |
| Mar 31, 2023 | 70.00 Mn |
| Dec 31, 2022 | 54.57 Mn |
| Sep 30, 2022 | 6.21 Mn |
| Jun 30, 2022 | 239,000.00 |
| Mar 31, 2022 | 2.62 Mn |
| Dec 31, 2021 | 150,000.00 |
| Sep 30, 2021 | 10.36 Mn |
| Jun 30, 2021 | 1.07 Mn |
| Mar 31, 2021 | 1.56 Mn |
| Dec 31, 2020 | 17.20 Mn |
| Sep 30, 2020 | 846,000.00 |
| Jun 30, 2020 | 41.69 Mn |
| Mar 31, 2020 | 2.57 Mn |